Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Steven Pai, PhD

    TitlePostdoctoral Scholar
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address513 Parnassus Ave, Med Sci
    San Francisco CA 94122
    Phone415-514-9301
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California, DavisPh.D.Cancer Immunobiology2015
      National Taiwan University M.S.Cancer Immunology2009
      National Taiwan UniversityD.V.M.School of Veterinary Medicine2006

      Collapse ORNG Applications 
      Collapse Faculty Mentoring

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Stolfi JL, Pai CS, Murphy WJ. Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations. FEBS J. 2016 May; 283(9):1595-606. PMID: 26640088.
        View in: PubMed
      2. Mall C, Sckisel GD, Proia DA, Mirsoian A, Grossenbacher SK, Pai CS, Chen M, Monjazeb AM, Kelly K, Blazar BR, Murphy WJ. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016 Feb; 5(2):e1075114. PMID: 27057446.
        View in: PubMed
      3. Mirsoian A, Bouchlaka MN, Sckisel GD, Chen M, Pai CC, Maverakis E, Spencer RG, Fishbein KW, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Taub DD, Murphy WJ. Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J Exp Med. 2014 Nov 17; 211(12):2373-83. PMID: 25366964; PMCID: PMC4235633.
      4. Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1899-904. PMID: 25064746; PMCID: PMC4254314 [Available on 12/01/15].
      5. Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M. Treatment of chronic graft-versus-host disease with bortezomib. Blood. 2014 Sep 4; 124(10):1677-88. PMID: 25009225; PMCID: PMC4155274.
      6. Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ. IFN-? receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation. J Immunol. 2012 Aug 15; 189(4):2033-42. PMID: 22778394; PMCID: PMC3509544.
      7. Pai CC, Kuo TF, Mao SJ, Chuang TF, Lin CS, Chu RM. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid. Vet Immunol Immunopathol. 2011 Feb 15; 139(2-4):187-99. PMID: 21051091.
        View in: PubMed
      8. Lin CY, Chuang TF, Liao KW, Huang YJ, Pai CC, Chu RM. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity. Cancer Lett. 2008 Dec 18; 272(2):285-95. PMID: 18760876.
        View in: PubMed
      Steven's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP